Heart Transplantation in a Case of Scimitar Syndrome

Fumiya Yoneyama1, Travis J Wilder1, Michiaki Imamura1

  • 1Division of Congenital Heart Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.

Insights

This study details a novel surgical technique for heart transplantation in a patient with complex congenital heart defects, including tetralogy of Fallot and scimitar syndrome. The innovative scimitar vein cuff translocation technique minimizes obstruction risk.

Area of Science:

  • Cardiology
  • Thoracic Surgery
  • Congenital Heart Disease

Background:

  • Tetralogy of Fallot (TOF) and hypertrophic cardiomyopathy (HCM) are complex cardiac conditions.
  • Scimitar syndrome, characterized by anomalous pulmonary venous return, presents unique surgical challenges.
  • Simultaneous occurrence of TOF, HCM, and scimitar syndrome is exceptionally rare.

Observation:

  • A patient presented with the rare triad of tetralogy of Fallot, hypertrophic cardiomyopathy, and scimitar syndrome.
  • Standard surgical approaches may be insufficient or carry high risks for such complex anatomy.
  • The need for an innovative solution to manage the scimitar vein during heart transplantation was identified.

Findings:

  • A novel surgical technique involving the creation and translocation of a scimitar vein cuff from a donor heart was successfully implemented.
  • This technique effectively rerouted the anomalous pulmonary venous return associated with scimitar syndrome.
  • The procedure facilitated successful orthotopic heart transplantation in a highly complex clinical scenario.

Implications:

  • This innovative scimitar vein cuff translocation technique offers a promising solution to prevent postoperative scimitar vein obstruction.
  • The described surgical strategy may be applicable to other complex congenital heart disease cases requiring heart transplantation.
  • This case highlights the importance of surgical ingenuity in managing rare and challenging cardiovascular conditions.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
106
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
124
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
129